LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals

被引:11
|
作者
Poli, Andrea [1 ,31 ]
Catapano, Alberico L. [2 ,3 ]
Corsini, Alberto [2 ]
Manzato, Enzo [4 ,5 ]
Werba, Jose Pablo [6 ]
Catena, Gabriele [7 ]
Cetin, Irene [8 ,9 ]
Cicero, Arrigo F. G. [10 ,11 ]
Cignarella, Andrea [4 ,12 ]
Colivicchi, Furio [13 ,14 ]
Consoli, Agostino [15 ,16 ]
Landi, Francesco [17 ,18 ]
Lucarelli, Maurizio [19 ]
Manfellotto, Dario [20 ,21 ]
Marrocco, Walter [22 ]
Parretti, Damiano [23 ]
Filardi, Pasquale Perrone [24 ,25 ]
Pirillo, Angela [3 ,26 ]
Sesti, Giorgio [27 ,28 ]
Volpe, Massimo [29 ,30 ]
Marangoni, Franca [1 ]
机构
[1] NFI Nutr Fdn Italy, Milan, Italy
[2] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy
[3] IRCCS Multimed, Ctr Study Dyslipidaemias, Sesto S Giovanni, Milan, Italy
[4] Univ Padua, Dept Med, Padua, Italy
[5] SISA Italian Soc Study Atherosclerosis, Parma, Italy
[6] IRCCS, Monzino Cardiol Ctr, Unit Atherosclerosis Prevent, Milan, Italy
[7] SISMED Italian Soc Med Sci, Rome, Italy
[8] Univ Milan, Hosp Buzzi, Dept Woman & Mother & Neonate, Milan, Italy
[9] SIGO Italian Soc Gynecol & Obstet, Rome, Italy
[10] IRCCS AOU Bologna, Hypertens & Cardiovasc Risk Res Ctr, Med & Surg Sci Dept, Bologna, Italy
[11] SINut Italian Nutraceut Soc, Bologna, Italy
[12] Italian Res Ctr Gender Hlth & Med, Rome, Italy
[13] San Filippo Neri Hosp, Div Clin Cardiol, Rome, Italy
[14] ANMCO Italian Natl Assoc Hosp Cardiologists, Florence, Italy
[15] Univ G DAnnunzio, Dept Med & Aging Sci, Chieti, Italy
[16] SID Italian Soc Diabetol, Rome, Italy
[17] Fdn Policlin Univ A Gemelli IRCSS, Rome, Italy
[18] SIGG Italian Soc Gerontol & Geriatr, Florence, Italy
[19] SNaMID Natl Soc Med Educ Gen Practice, Florence, Italy
[20] Fatebenefratelli Hosp, Dept Internal Med, Rome, Italy
[21] FADOI Federat Assoc Hosp Internists, Rome, Italy
[22] SIMPeSV & FIMMG Italian Soc Prevent & Lifestyle Me, Rome, Italy
[23] SIMG talian Soc Gen Med, Florence, Italy
[24] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy
[25] SIC Italian Soc Cardiol, Rome, Italy
[26] E Bassini Hosp, Ctr Study Atherosclerosis, Milan, Italy
[27] Sapienza Univ Rome, Dept Clin & Mol Med, Rome, Italy
[28] SIMI Italian Soc Internal Med, Rome, Italy
[29] Sapienza Univ Rome, Dept Clin & Mol Med, Rome, Italy
[30] SIPREC Italian Soc Cardiovasc Prevent, Genoa, Italy
[31] NFI Nutr Fdn Italy, Viale Tunisia 38, Milan, Italy
关键词
LDL-cholesterol; Cardiovascular disease; Cardiovascular risk; Primary prevention; Risk factors; CORONARY-HEART-DISEASE; BLOOD-PRESSURE; RISK SCORE; MYOCARDIAL-INFARCTION; STATIN NONADHERENCE; INDIVIDUAL DATA; FAMILY-HISTORY; POSITION PAPER; GENETIC RISK; MORTALITY;
D O I
10.1016/j.numecd.2022.10.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Although adequate clinical management of patients with hypercholesterolemia without a history of known cardiovascular disease is essential for prevention, these subjects are often disregarded. Furthermore, the scientific literature on primary cardiovascular prevention is not as rich as that on secondary prevention; finally, physicians often lack adequate tools for the effective management of subjects in primary prevention and have to face some unsolved relevant issues. This document aims to discuss and review the evidence available on this topic and pro-vide practical guidance.Data synthesis: Available algorithms and risk charts represent the main tool for the assessment of cardiovascular risk in patients in primary prevention. The accuracy of such an estimate can be substantially improved considering the potential contribution of some additional risk factors (C-reactive protein, lipoprotein(a), family history of cardiovascular disease) and conditions (envi-ronmental pollution, sleep quality, socioeconomic status, educational level) whose impact on the cardiovascular risk has been better understood in recent years. The availability of non-invasive procedures to evaluate subclinical atherosclerosis may help to identify subjects needing an earlier intervention. Unveiling the presence of these conditions will improve cardiovascular risk estimation, granting a more appropriate intervention.Conclusions: The accurate assessment of cardiovascular risk in subjects in primary prevention with the use of algorithms and risk charts together with the evaluation of additional factors will allow physicians to approach each patient with personalized strategies, which should translate into an increased adherence to therapy and, as a consequence, a reduced cardiovas-cular risk. 2022 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:245 / 257
页数:13
相关论文
共 50 条
  • [1] Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study
    Quispe, Renato
    Elshazly, Mohamed B.
    Zhao, Di
    Toth, Peter P.
    Puri, Rishi
    Virani, Salim S.
    Blumenthal, Roger S.
    Martin, Seth S.
    Jones, Steven R.
    Michos, Erin D.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (15) : 1597 - 1605
  • [2] Evolution of More Aggressive LDL-Cholesterol Targets and Therapies for Cardiovascular Disease Prevention
    Jones, Jeffrey E.
    Tang, Kevin S.
    Barseghian, Ailin
    Wong, Nathan D.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [3] Barriers and facilitators among health professionals in primary care to prevention of cardiometabolic diseases: A systematic review
    Waendell, Per E.
    de Waard, Anne-Karien M.
    Holzmann, Martin J.
    Gornitzki, Carl
    Lionis, Christos
    de Wit, Niek
    Sondergaard, Jens
    Sonderlund, Anders L.
    Kral, Norbert
    Seifert, Bohumil
    Korevaar, Joke C.
    Schellevis, Francois G.
    Carlsson, Axel C.
    FAMILY PRACTICE, 2018, 35 (04) : 383 - 398
  • [4] Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
    Quispe, Renato
    Martin, Seth Shay
    Michos, Erin Donelly
    Lamba, Isha
    Blumenthal, Roger Scott
    Saeed, Anum
    Lima, Joao
    Puri, Rishi
    Nomura, Sarah
    Tsai, Michael
    Wilkins, John
    Ballantyne, Christie Mitchell
    Nicholls, Stephen
    Jones, Steven Richard
    Elshazly, Mohamed Badreldin
    EUROPEAN HEART JOURNAL, 2021, 42 (42) : 4324 - +
  • [5] Interventions for Adherence Improvement in the Primary Prevention of Cardiovascular Diseases: Expert Consensus Statement
    Ihm, Sang Hyun
    Kim, Kwang-Il
    Lee, Kyung Jin
    Won, Jong Won
    Na, Jin Oh
    Rha, Seung-Woon
    Kim, Hack-Lyoung
    Kim, Sang-Hyun
    Shin, Jinho
    KOREAN CIRCULATION JOURNAL, 2022, 52 (01) : 1 - 33
  • [6] Expert opinion of the Polish Cardiac Society on therapeutic targets for LDL cholesterol levels in secondary prevention of myocardial infarction
    Mitkowski, Przemyslaw
    Witkowski, Adam
    Stepinska, Janina
    Banach, Maciej
    Jankowski, Piotr
    Gasior, Mariusz
    Wita, Krystian
    Bartus, Stanislaw
    Burchardt, Pawel
    Farkowski, Michal M.
    Gierlotka, Marek
    Gil, Robert
    Leszek, Przemyslaw
    Sterlinski, Maciej
    Szymanski, Piotr
    Tajstra, Mateusz
    Tycinska, Agnieszka
    Wojakowski, Wojciech
    Haberka, Maciej
    Lesiak, Maciej
    KARDIOLOGIA POLSKA, 2023, 81 (7-8) : 818 - 823
  • [7] Optimal LDL cholesterol levels in young and old patients with type 2 diabetes for secondary prevention of cardiovascular diseases are different
    Jeong, Chaiho
    Kim, Bongseong
    Kim, Jinyoung
    Baek, Hansang
    Kim, Mee Kyoung
    Sohn, Tae-Seo
    Baek, Ki-Hyun
    Song, Ki-Ho
    Son, Hyun-Shik
    Han, Kyungdo
    Kwon, Hyuk-Sang
    ENDOCRINE CONNECTIONS, 2023, 12 (11)
  • [8] 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
    -Jones, Donald M. Lloyd
    Morris, Pamela B.
    Ballantyne, Christie M.
    Birtcher, Kim K.
    Covington, Ashleigh M.
    DePalma, Sondra M.
    Bhave, Nicole M.
    Minissian, Margo B.
    Orringer, Carl E.
    Smith, Sidney C.
    Waring, Ashley Arana
    Wilkins, John T.
    Aggarwal, Niti R.
    Bozkurt, Biykem
    Erwin, John P., III
    Krittanawong, Chayakrit
    Kumbhani, Dharam J.
    Panjrath, Gurusher S.
    Sala-Mercado, Javier A.
    Winchester, David E.
    Coylewright, Megan
    Edward, T. A.
    Gates, Cathleen C.
    Kovacs, Richard J.
    Mullen, Brendan
    Allen, Joseph M.
    Dearborn, Amy
    Ronan, Grace D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (14) : 1366 - 1418
  • [9] Factors Associated With Achievement of Blood Pressure, Low-Density Lipoprotein Cholesterol (LDL-C), and Glycemic Targets for Primary Prevention of Cardiovascular Diseases Among High Cardiovascular Risk Malaysians in Primary Care
    Baharudin, Noorhida
    Ramli, Anis Safura
    Ramland, Siti Syazwani
    Badlie-Hisham, Nurul Izzaty
    Mohamed-Yassin, Mohamed-Syarif
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2023, 14
  • [10] Primary cardiovascular risk prediction by LDL-cholesterol in Caucasian middle-aged and older adults: a joint analysis of three cohorts
    Hilvo, Mika
    Dhar, Indu
    Laaperi, Mitja
    Lysne, Vegard
    Sulo, Gehard
    Tell, Grethe S.
    Jousilahti, Pekka
    Nygard, Ottar K.
    Brenner, Hermann
    Schoettker, Ben
    Laaksonen, Reijo
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (03) : E128 - E137